GoodRx Holdings, Inc. (GDRX) Return on equity 2020–2025
GoodRx Holdings, Inc. (GDRX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
4.9%FY2025 · since FY2020: -41.3% → 4.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 4.9% | +2.7 pp |
| FY2024 | 2.3% | +3.4 pp |
| FY2023 | -1.2% | +2.9 pp |
| FY2022 | -4.0% | -1.0 pp |
| FY2021 | -3.0% | +38.2 pp |
| FY2020 | -41.3% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice